Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology.

Small molecules are widely used in chemical biology without complete knowledge of their target profile, at risk of deriving conclusions that ignore potential confounding effects from unknown off-target interactions. The prediction and further experimental confirmation of novel affinities for PJ34 on Pim1 (IC(50) = 3.7 μM) and Pim2 (IC(50) = 16 μM) serine/threonine kinases, together with their involvement in many of the processes relevant to PARP biology, questions the appropriateness of using PJ34 as a chemical tool to probe the biological role of PARP1 and PARP2 at the high micromolar concentrations applied in most studies.

[1]  Csaba Szabó,et al.  Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.

[2]  David S. Goodsell,et al.  The RCSB Protein Data Bank: redesigned web site and web services , 2010, Nucleic Acids Res..

[3]  Leif E. Peterson,et al.  Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis , 2002, Alimentary pharmacology & therapeutics.

[4]  Jordi Mestres,et al.  MIMIC: A molecular‐field matching program. Exploiting applicability of molecular similarity approaches , 1997 .

[5]  Stephen V Frye,et al.  The art of the chemical probe. , 2010, Nature chemical biology.

[6]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[7]  V. Schreiber,et al.  Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.

[8]  R. Lahesmaa,et al.  Expression of human pim family genes is selectively up‐regulated by cytokines promoting T helper type 1, but not T helper type 2, cell differentiation , 2005, Immunology.

[9]  Ian Collins,et al.  Probing the Probes: Fitness Factors For Small Molecule Tools , 2010, Chemistry & biology.

[10]  J. Mestres,et al.  In Silico Receptorome Screening of Antipsychotic Drugs , 2010, Molecular informatics.

[11]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[12]  R. Schulz,et al.  Inhibition of matrix metalloproteinase-2 by PARP inhibitors. , 2009, Biochemical and biophysical research communications.

[13]  Stuart L Schreiber,et al.  Small molecules: the missing link in the central dogma , 2005, Nature chemical biology.

[14]  Andreas Bender,et al.  From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.

[15]  S. Gollin,et al.  Spindle Multipolarity Is Prevented by Centrosomal Clustering , 2005, Science.

[16]  F. Prinz,et al.  Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.

[17]  Jacques Guilbert,et al.  High throughput drug profiling , 2000, Journal of automated methods & management in chemistry.

[18]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[19]  Bryan L. Roth,et al.  Chemical Informatics and Target Identification in a Zebrafish Phenotypic Screen , 2011, Nature chemical biology.

[20]  M. Nawijn,et al.  For better or for worse: the role of Pim oncogenes in tumorigenesis , 2011, Nature Reviews Cancer.

[21]  N. Bhattacharya,et al.  Pim-1 associates with protein complexes necessary for mitosis , 2002, Chromosoma.

[22]  Tudor I. Oprea,et al.  A crowdsourcing evaluation of the NIH chemical probes. , 2009, Nature chemical biology.

[23]  John P. Overington,et al.  Probing the links between in vitro potency, ADMET and physicochemical parameters , 2011, Nature Reviews Drug Discovery.

[24]  S. Izraeli,et al.  A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells , 2011, BMC Cancer.

[25]  D. Stauffer,et al.  The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest. , 2011, DNA repair.

[26]  J. Weigelt,et al.  Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors , 2012, Nature Biotechnology.

[27]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[28]  Tudor I. Oprea,et al.  Linking Pharmacology to Clinical Reports: Cyclobenzaprine and Its Possible Association With Serotonin Syndrome , 2011, Clinical pharmacology and therapeutics.

[29]  M. Altmeyer,et al.  Inhibition of ADP ribosylation prevents and cures helicobacter-induced gastric preneoplasia. , 2010, Cancer research.